Picture Berlin Partner Top News Healthtech Company Mika 650x100px
Document › Details

Microsaic Systems plc. (6/21/18). "Press Release: Distribution Agreement with Amedis, spol. s ro.".

Organisation Organisation Microsaic Systems plc (AIM: MSYS)
Products Product 4500 MiD® desktop MS system
  Product 2 NMR spectroscopy
Person Person Tracey, Glenn (Microsaic 201709– CEO joined 201503 as COO before Cambridge Temperature Concepts + PerkinElmer)

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, is pleased to announce that it has signed a distribution agreement with Amedis, spol. s ro. ("Amedis"). Amedis will be the exclusive distributor of Microsaic-branded 4500 MiD® MS detectors in Slovakia.

Founded in 1991, Amedis distributes and provides application and service support for global brands across a wide range of technologies, including Liquid Chromatography Mass Spectrometry ("LCMS"), Inductively Coupled Plasma Mass Spectrometry ("ICPMS"), Gas Chromatography Mass Spectrometry ("GCMS") and Nuclear Magnetic Resonance ("NMR"). Additionally, Amedis has expertise in medical technologies, such as Linear Accelerators, Medical Imaging and Dosimetry for Radiation Therapy.

Glenn Tracey, CEO of Microsaic, commented, "Amedis is the perfect partner to distribute our compact, point of need MS technology, already having an impressive technology portfolio, unrivaled technical expertise, and full understanding of end user applications .

"Central Europe has shown impressive growth and opportunity for scientific instrumentation in recent years, and this agreement supports our growth strategy with select partners across the European region."

Milos Sebedinsky, CEO of Amedis, added: "Amedis appreciates the possibility to widen its product portfolio with the top quality Microsaic product range, especially in the field of flash chromatography purification. Our plan also is to integrate 4500 MiD ® with High Performance Liquid Chromatography systems we are selling, as a complement to other detectors."


Microsaic Systems plc
Glenn Tracey, CEO
Bevan Metcalf, FD
+44 (0) 1483 751 577

N+1 Singer (Nominated Adviser & Broker)
Shaun Dobson
Liz Yong
+44 (0)20 7496 3000

IFC Advisory Ltd (Financial PR)
Graham Herring
Heather Armstrong
Florence Chandler
+44 (0)20 3934 6630

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company is working with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.

Microsaic's core product, the 4500 MiD®, is a robust and compact MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. For more information, please go to .

Record changed: 2023-06-05


Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Microsaic Systems plc (AIM: MSYS)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Berlin Partner BIO 2024 International Convention San Diego 650x300px

» top